Abstract:Flucytosine, CAS #2022-85-7, crystallizes in the tetragonal space group P 41212 (#94) with a = 6.643768(27), c = 23.89009(10) Å, V = 1054.500(7) Å 3 , and Z = 8. In this work, the sample was obtained from the United States Pharmacopeial Convention (USP) Lot #R03100 and analyzed as-received. The room temperature (295 K) crystal structure was refined using synchrotron ( λ = 0.412826 Å) powder diffraction data and optimized using the density functional theory (DFT). When looking down the a -axis, the crystal structure consists of multiple ribbon-like structures stacked into columns. The powder X-ray diffraction pattern of the compound has been submitted to ICDD® for inclusion in the Powder Diffraction FileTM (PDF®). The agreement of the Rietveld-refined and DFT-optimized structures is good, with the largest difference in the external amine group with an overall root mean displacement of 0.056 Å. There is also evidence of unit cell expansion at higher temperatures, as the volume of the unit cell at 298 K was 1.6–1.9% greater than the two unit cells obtained at 150 K. A N–H⋯O hydrogen bond exists in the inter-ribbon region between the flucytosine molecules, resulting in a 3D hydrogen bond network.

X-ray Powder Diffraction Data for Bisacodyl, C22H19NO4

Crystal Structure of Bis(1-Benzoylacetone)-p-naphthalenediimine, C30H26N2O2

Powder X-ray Diffraction of 1-(4-aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1h)-pyridinone, C15H19N3O2

X-ray powder diffraction data for mosapride dihydrogen citrate dihydrate

X-ray Powder Diffraction Data for Thiamphenicol, C12H15Cl2NO5S

Ab initio structure determination of bethanechol chloride

X-ray Powder Diffraction Data for 5-Chloro-n-(4-(5,6-dihydro-3-(4-morpholinyl)-2-oxo-1(2h)-pyridinyl)phenyl)-pentanamide, C20H26ClN3O3

Synthesis and Structural Characterization of Amidine, Amide, Urea and Isocyanate Derivatives of the Amino-closo-dodecaborate Anion [B12H11NH3]−

Powder Diffraction Data and Mesomorphic Properties for 4-Butyloxyphenyl 4'-Decyloxybenzoate

Crystal structure and X-ray powder diffraction data for Lumateperone tosylate

CCDC 2168820: Experimental Crystal Structure Determination

The crystal structure of N , N -(ethane-1,1-diyl)dibenzamide, C 16 H 16 N 2 O 2

Powder X-ray diffraction of acalabrutinib dihydrate Form III, C 26 H 23 N 7 O 2 (H 2 O) 2

Crystal structure of diaqua[bis( μ 2 -pyridine 2,6-dicarboxylato) bismuth(III) potassium(I)], C 14 H 10 BiKN 2 O 10

Powder X-ray diffraction of flucytosine, C4H4FN3O

X-ray Powder Diffraction Data for Cobalt Tris-Ethylenediamine Bromide Trihydrate and Cobalt Tris-Ethylenediamine Iodide Hemihydrate

Crystal Structure and X-ray Powder Diffraction Data for Ruxolitinib

The crystal structure of N,N′-carbonylbis(2,6-difluorobenzamide), C 15 H 8 F 4 N 2 O 3

Crystal structure of a novel bis(guanidiniums) compound incorporated by sulfate anion

Crystal Structure of 2,4-Dibenzoyl-n,n-dimethylbenzenamine, C22h19no2

Using synchrotron high-resolution powder X-ray diffraction for the structure determination of a new cocrystal formed by two active principle ingredients